News23/Ratings0
Latest news
23 items- 13D/GSEC Form SC 13G/A filed by Omega Alpha SPAC (Amendment)SC 13G/A - Omega Alpha SPAC (0001832010) (Subject)
- 13D/GSEC Form SC 13G/A filed by Omega Alpha SPAC (Amendment)SC 13G/A - Omega Alpha SPAC (0001832010) (Subject)
- 13D/GSEC Form SC 13G/A filed by Omega Alpha SPAC (Amendment)SC 13G/A - Omega Alpha SPAC (0001832010) (Subject)
- 13D/GSEC Form SC 13G/A filed by Omega Alpha SPAC (Amendment)SC 13G/A - Omega Alpha SPAC (0001832010) (Subject)
- SECSEC Form 15-12G filed by Omega Alpha SPAC15-12G - Omega Alpha SPAC (0001832010) (Filer)
- SECSEC Form 25-NSE filed by Omega Alpha SPAC25-NSE - Omega Alpha SPAC (0001832010) (Subject)
- SECOmega Alpha SPAC filed SEC Form 8-K: Other Events8-K - Omega Alpha SPAC (0001832010) (Filer)
- SECSEC Form 10-Q filed by Omega Alpha SPAC10-Q - Omega Alpha SPAC (0001832010) (Filer)
- SECSEC Form 10-Q/A filed by Omega Alpha SPAC (Amendment)10-Q/A - Omega Alpha SPAC (0001832010) (Filer)
- SECSEC Form 10-Q/A filed by Omega Alpha SPAC (Amendment)10-Q/A - Omega Alpha SPAC (0001832010) (Filer)
- SECSEC Form 10-Q filed by Omega Alpha SPAC10-Q - Omega Alpha SPAC (0001832010) (Filer)
- SECSEC Form 10-Q filed by Omega Alpha SPAC10-Q - Omega Alpha SPAC (0001832010) (Filer)
- 13D/GSEC Form SC 13G filed by Omega Alpha SPACSC 13G - Omega Alpha SPAC (0001832010) (Subject)
- 13D/GSEC Form SC 13G filed by Omega Alpha SPACSC 13G - Omega Alpha SPAC (0001832010) (Subject)
- 13D/GSEC Form SC 13G/A filed by Omega Alpha SPAC (Amendment)SC 13G/A - Omega Alpha SPAC (0001832010) (Subject)
- 13D/GSEC Form SC 13G/A filed by Omega Alpha SPAC (Amendment)SC 13G/A - Omega Alpha SPAC (0001832010) (Subject)
- SECSEC Form 10-Q/A filed by Omega Alpha SPAC (Amendment)10-Q/A - Omega Alpha SPAC (0001832010) (Filer)
- SECOmega Alpha SPAC filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review8-K - Omega Alpha SPAC (0001832010) (Filer)
- PROmega Funds Closes Oversubscribed $650 Million Fund VII to Invest in Transformative Life Science CompaniesBOSTON, Dec. 17, 2021 /PRNewswire/ -- Omega Funds, a leading international healthcare venture capital firm focused on delivering impactful medicines to patients, today announced it has closed its seventh and largest fund with $650 million in limited partner capital commitments. The new fund, Omega Fund VII, L.P. ("Fund VII"), was oversubscribed, exceeding the firm's targeted raise of $500 million, and included strong support from both new and existing limited partners. With Fund VII, the firm will continue to execute on its strategy of creating and investing in life sciences companies in the US and Europe that target severe, unmet medical needs. Since its inception in 2004, Omega Funds has r
- SECSEC Form 10-Q filed by Omega Alpha SPAC10-Q - Omega Alpha SPAC (0001832010) (Filer)
- SECSEC Form 10-Q filed by Omega Alpha SPAC10-Q - Omega Alpha SPAC (0001832010) (Filer)
- SECSEC Form 10-Q filed by Omega Alpha SPAC10-Q - Omega Alpha SPAC (0001832010) (Filer)
- 13D/GSEC Form SC 13G filed by Omega Alpha SPACSC 13G - Omega Alpha SPAC (0001832010) (Subject)